Multidrug resistant Acinetobacter baumannii in veterinary medicine – Emergence of an underestimated pathogen?;Multiresistente Acinetobacter baumannii in der veterinärmedizin – Vormarsch eines unterschätzten krankheitserregers?

Berliner und Munchener Tierarztliche Wochenschrift

Volumn 127, Issue 11-12, 2014, Pages 435-446

  Müller, Stefanie ^a   Janßen, Traute ^a   Wieler, Lothar H ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Clinical impact; Companion animal; Epidemiology; Multidrug resistance

Indexed keywords

ACINETOBACTER BAUMANNII; ANIMALIA; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE SPP.; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ANIMAL; ANIMAL DISEASE; CROSS INFECTION; DRUG EFFECTS; MICROBIOLOGY; MULTIDRUG RESISTANCE; PATHOGENICITY; STATISTICS AND NUMERICAL DATA; VETERINARY; VETERINARY MEDICINE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANIMAL DISEASES; ANIMALS; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; VETERINARY MEDICINE;

EID: 84926303310     PISSN: 00059366     EISSN: None     Source Type: Journal    
DOI: 10.2376/0005-9366-127-435     Document Type: Article

References (124)

1. A bbott Y, O'Mahony R, Leonard N, Quinn PJ, van der Reijden T, Dijkshoorn L, Fanning S (2005): Characterization of a 2.6 kbp variable region within a class 1 integron found in an Acinetobacter baumannii strain isolated from a horse. J Antimicrob Chemother 55: 367-370.
2. A hmed AM, Motoi Y, Sato M, Maruyama A, Watanabe H, Fukumoto Y, Shimamoto T (2007): Zoo animals as reservoirs of gram-negative bacteria harboring integrons and antimicrobial resistance genes. Appl Environ Microbiol 73: 6686-6690.
3. Bentz AI, Wilkins PA, MacGillivray KC, Barr BS, Palmer JE (2002): Severe thrombocytopenia in 2 thoroughbred foals with sepsis and neonatal encephalopathy. J Vet Intern Med 16: 494- 497.
4. Bergogne-Berezin E, Towner KJ (1996): Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin Microbiol Rev 9: 148-165.
5. Berlau J, Aucken HM, Houang E, Pitt TL (1999): Isolation of Acinetobacter spp. including A. baumannii from vegetables: implications for hospital-acquired infections. J Hosp Infect 42: 201-204.
6. Black DM, Rankin SC, King LG (2009): Antimicrobial therapy and aerobic bacteriologic culture patterns in canine intensive care unit patients: 74 dogs (January-June 2006). J Vet Emerg Crit Care (San Antonio) 19: 489-495.
7. Boerlin P, Eugster S, Gaschen F, Straub R, Schawalder P (2001): Transmission of opportunistic pathogens in a veterinary teaching hospital. Vet Microbiol 82: 347-359.
8. Boguta L, Gradzki Z, Borges E, Maurin F, Kodjo A, Winiarczyk S (2002): Bacterial flora in foals with upper respiratory tract infections in Poland. J Vet Med B Infect Dis Vet Public Health 49: 294-297.
9. Bonomo RA, Szabo D (2006): Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa. Clin Infect Dis 43 Suppl 2: S49-56.
10. Bouvresse S, Socolovshi C, Berdjane Z, Durand R, Izri A, Raoult D, Chosidow O, Brouqui P (2011): No evidence of Bartonella quintana but detection of Acinetobacter baumannii in head lice from elementary schoolchildren in Paris. Comp Immunol Microbiol Infect Dis 34: 475-477.
11. Brachelente C, Wiener D, Malik Y, Huessy D (2007): A case of necrotizing fasciitis with septic shock in a cat caused by Acinetobacter baumannii. Vet Dermatol 18: 432-438.
12. Brosnahan MM (2008): Bacterial isolates and antimicrobial susceptibility phenotypes of equine specimens submitted to the Oklahoma Animal Disease and Diagnostic Laboratory 2005-2007. Oklahoma, Oklahoma State University.
13. Brown S, Amyes SG (2005): The sequences of seven class D beta-lactamases isolated from carbapenem-resistant Acinetobacter baumannii from four continents. Clin Microbiol Infect 11: 326-329.
14. Brown S, Amyes S (2006): OXA (beta)-lactamases in Acinetobacter: the story so far. J Antimicrob Chemother 57: 1-3.
15. Byrne-Bailey KG, Gaze WH, Kay P, Boxall AB, Hawkey PM, Wellington EM (2009): Prevalence of sulfonamide resistance genes in bacterial isolates from manured agricultural soils and pig slurry in the United Kingdom. Antimicrob Agents Chemother 53: 696-02.
16. Cefai C, Richards J, Gould FK, McPeake P (1990): An outbreak of Acinetobacter respiratory tract infection resulting from incomplete disinfection of ventilatory equipment. J Hosp Infect 15: 177-182.
17. Chaari A, Mnif B, Bahloul M, Mahjoubi F, Chtara K, Turki O, Gharbi N, Chelly H, Hammami A, Bouaziz M (2013): Acinetobacter baumannii ventilator-associated pneumonia: epidemiology, clinical characteristics, and prognosis factors. Int J Infect Dis 17: e1225-e1228.
18. Chen MZ, Hsueh PR, Lee LN, Yu CJ, Yang PC, Luh KT (2001): Severe community-acquired pneumonia due to Acinetobacter baumannii. Chest 120: 1072-1077.
19. Corvec S, Caroff N, Espaze E, Giraudeau C, Drugeon H, Reynaud A (2003): AmpC cephalosporinase hyperproduction in Acinetobacter baumannii clinical strains. J Antimicrob Chemother 52: 629-635.
20. Da Silva G, Dijkshoorn L, van der Reijden T, van Strijen B, Duarte A (2007): Identification of widespread, closely related Acinetobacter baumannii isolates in Portugal as a subgroup of European clone II. Clin Microbiol Infect 13: 190-195.
21. Damier-Piolle L, Magnet S, Bremont S, Lambert T, Courvalin P (2008): AdeIJK, a resistance-nodulation-cell division pump effluxing multiple antibiotics in Acinetobacter baumannii. Antimicrob Agents Chemother 52: 557-562.
22. Das AM, Paranjape VL (1986): Acinetobacter calcoaceticus in three cases of late abortion in water buffaloes. Vet Rec 118: 214.
23. Diancourt L, Passet V, Nemec A, Dijkshoorn L, Brisse S (2010): The population structure of Acinetobacter baumannii: expanding multiresistant clones from an ancestral susceptible genetic pool. PLoS One 5: e10034.
24. Dickie CW, Regnier JO (1978): Equine myositis and septicemia caused by Acinetobacter calcoaceticus infection. J Am Vet Med Assoc 172: 357-359.
25. Dijkshoorn L, Nemec A, Seifert H (2007): An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol 5: 939-951.
26. Diker KS, Arda M, Izgur H (1986): Isolation of Acinetobacter calcoaceticus from cows with metritis. Zentralbl Veterinarmed B 33: 632-633.
27. Endimiani A, Luzzaro F, Migliavacca R, Mantengoli E, Hujer AM, Hujer KM, Pagani L, Bonomo RA, Rossolini GM, Toniolo A (2007): Spread in an Italian hospital of a clonal Acinetobacter baumannii strain producing the TEM-92 extendedspectrum beta-lactamase. Antimicrob Agents Chemother 51: 2211-2214.
28. Endimiani A, Hujer KM, Hujer AM, Bertschy I, Rossano A, Koch C, Gerber V, Francey T, Bonomo RA, Perreten V (2011): Acinetobacter baumannii isolates from pets and horses in Switzerland: molecular characterization and clinical data. J Antimicrob Chemother 66: 2248-2254.
29. Ercolini D, Russo F, Nasi A, Ferranti P, Villani F (2009): Mesophilic and psychrotrophic bacteria from meat and their spoilage potential in vitro and in beef. Appl Environ Microbiol 75: 1990-2001.
30. Erganis O, Corlu M, Kaya O, Ates M (1988): Isolation of Acinetobacter calcoaceticus from septicaemic hens. Vet Rec 123: 374.
31. Eveillard M, Kempf M, Belmonte O, Pailhories H, Joly-Guillou ML (2013): Reservoirs of Acinetobacter baumannii outside the hospital and potential involvement in emerging human community- acquired infections. Int J Infect Dis 17: e802-805.
32. Ewers C, Grobbel M, Bethe A, Wieler LH, Guenther S (2011): Extended-spectrum beta-lactamases-producing gram-negative bacteria in companion animals: action is clearly warranted! Berl Munch Tierarztl Wochenschr 124: 94-101.
33. Falagas ME, Bliziotis IA, Siempos, II (2006a): Attributable mortality of Acinetobacter baumannii infections in critically ill patients: a systematic review of matched cohort and case-control studies. Crit Care 10: R48.
34. Falagas ME, Koletsi PK, Bliziotis IA (2006b): The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa. J Med Microbiol 55: 1619-1629.
35. Falagas ME, Karveli EA, Kelesidis I, Kelesidis T (2007): Community- acquired Acinetobacter infections. Eur J Clin Microbiol Infect Dis 26: 857-868.
36. Fournier PE, Richet H (2006): The epidemiology and control of Acinetobacter baumannii in health care facilities. Clin Infect Dis 42: 692-699.
37. Fournier PE, Vallenet D, Barbe V, Audic S, Ogata H, Poirel L, Richet H, Robert C, Mangenot S, Abergel C, Nordmann P, Weissenbach J, Raoult D, Claverie JM (2006): Comparative genomics of multidrug resistance in Acinetobacter baumannii. PLoS Genet 2: e7.
38. Francey T, Gaschen F, Nicolet J, Burnens AP (2000): The role of Acinetobacter baumannii as a nosocomial pathogen for dogs and cats in an intensive care unit. J Vet Intern Med 14: 177-183.
39. Garcia-Garmendia JL, Ortiz-Leyba C, Garnacho-Montero J, Jimenez-Jimenez FJ, Perez-Paredes C, Barrero-Almodovar AE, Gili-Miner M (2001): Risk factors for Acinetobacter baumannii nosocomial bacteremia in critically ill patients: a cohort study. Clin Infect Dis 33: 939-946.
40. Gerner-Smidt P, Tjernberg I, Ursing J (1991): Reliability of phenotypic tests for identification of Acinetobacter species. J Clin Microbiol 29: 277-282.
41. Giamarellou H, Antoniadou A, Kanellakopoulou K (2008): Acinetobacter baumannii: a universal threat to public health? Int J Antimicrob Agents 32: 106-119.
42. Gootz TD, Marra A (2008): Acinetobacter baumannii: an emerging multidrug-resistant threat. Expert Rev Anti Infect Ther 6: 309-325.
43. Grami R, Dahmen S, Mansour W, Mehri W, Haenni M, Aouni M, Madec JY (2014): blaCTX-M-15-Carrying F2:A-:B- Plasmid in Escherichia coli from Cattle Milk in Tunisia. Microb Drug Resist 20(4): 344-349.
44. Guenther S, Grobbel M, Beutlich J, Bethe A, Friedrich ND, Goedecke A, Lubke-Becker A, Guerra B, Wieler LH, Ewers C (2010): CTX-M-15-type extended-spectrum beta-lactamasesproducing Escherichia coli from wild birds in Germany. Environ Microbiol Rep 2: 641-645.
45. Guenther S, Aschenbrenner K, Stamm I, Bethe A, Semmler T, Stubbe A, Stubbe M, Batsajkhan N, Glupczynski Y, Wieler LH, Ewers C (2012): Comparable high rates of extended-spectrum- beta-lactamase-producing Escherichia coli in birds of prey from Germany and Mongolia. PLoS One 7: e53039.
46. Gurung M, Nam HM, Tamang MD, Chae MH, Jang GC, Jung SC, Lim SK (2013): Prevalence and antimicrobial susceptibility of Acinetobacter from raw bulk tank milk in Korea. J Dairy Sci 96: 1997-2002.
47. Hamouda A, Vali L, Amyes SG (2008): Gram-negative nonfermenting bacteria from food-producing animals are low risk for hospital-acquired infections. J Chemother 20: 702-708.
48. Hamouda A, Findlay J, Al Hassan L, Amyes SG (2011): Epidemiology of Acinetobacter baumannii of animal origin. Int J Antimicrob Agents 38: 314-318.
49. Hanlon GW (2005): The emergence of multidrug resistant Acinetobacter species: a major concern in the hospital setting. Lett Appl Microbiol 41: 375-378.
50. Hartmann A, Locatelli A, Amoureux L, Depret G, Jolivet C, Gueneau E, Neuwirth C (2012): Occurrence of CTX-M Producing Escherichia coli in Soils, Cattle, and Farm Environment in France (Burgundy Region). Front Microbiol 3: 83.
51. Heritier C, Poirel L, Nordmann P (2006): Cephalosporinase overexpression resulting from insertion of ISAba1 in Acinetobacter baumannii. Clin Microbiol Infect 12: 123-130.
52. Higgins PG, Dammhayn C, Hackel M, Seifert H (2010): Global spread of carbapenem-resistant Acinetobacter baumannii. J Antimicrob Chemother 65: 233-238.
53. Hou PF, Chen XY, Yan GF, Wang YP, Ying CM (2012): Study of the correlation of imipenem resistance with efflux pumps AdeABC, AdeIJK, AdeDE and AbeM in clinical isolates of Acinetobacter baumannii. Chemotherapy 58: 152-158.
54. Houang ET, Chu YW, Leung CM, Chu KY, Berlau J, Ng KC, Cheng AF (2001): Epidemiology and infection control implications of Acinetobacter spp. in Hong Kong. J Clin Microbiol 39: 228-234.
55. Hsueh PR, Teng LJ, Chen CY, Chen WH, Yu CJ, Ho SW, Luh KT (2002): Pandrug-resistant Acinetobacter baumannii causing nosocomial infections in a university hospital, Taiwan. Emerg Infect Dis 8: 827-832.
56. Hujer KM, Hamza NS, Hujer AM, Perez F, Helfand MS, Bethel CR, Thomson JM, Anderson VE, Barlow M, Rice LB, Tenover FC, Bonomo RA (2005): Identification of a new allelic variant of the Acinetobacter baumannii cephalosporinase, ADC-7 betalactamase: defining a unique family of class C enzymes. Antimicrob Agents Chemother 49: 2941-2948.
57. Huys G, Cnockaert M, Vaneechoutte M, Woodford N, Nemec A, Dijkshoorn L, Swings J (2005): Distribution of tetracycline resistance genes in genotypically related and unrelated multiresistant Acinetobacter baumannii strains from different European hospitals. Res Microbiol 156: 348-355.
58. Huys G, Bartie K, Cnockaert M, Hoang Oanh DT, Phuong NT, Somsiri T, Chinabut S, Yusoff FM, Shariff M, Giacomini M, Teale A, Swings J (2007): Biodiversity of chloramphenicolresistant mesophilic heterotrophs from Southeast Asian aquaculture environments. Res Microbiol 158: 228-235.
59. Iverson W, Connelly M (1981): Acinetobacter infection associated with pneumonia in an orangutan. Primates 22: 587-589.
60. Jawad A, Seifert H, Snelling AM, Heritage J, Hawkey PM (1998): Survival of Acinetobacter baumannii on dry surfaces: comparison of outbreak and sporadic isolates. J Clin Microbiol 36: 1938-1941.
61. Jokisalo J, Bryan J, Legget B, Abbott Y, Katz LM (2010): Multipledrug resistant Acinetobacter baumannii bronchopneumonia in a colt following intensive care treatment. Equine Vet Educ 22: 281-286.
62. Kempf M, Abdissa A, Diatta G, Trape JF, Angelakis E, Mediannikov O, La Scola B, Raoult D (2012): Detection of Acinetobacter baumannii in human head and body lice from Ethiopia and identification of new genotypes. Int J Infect Dis 16: e680-683.
63. Kester RM, Lesser SA, Dowd LL (1993): Bacteria isolated from equine respiratory cultures. Equine Pract 15: 33-36.
64. La Scola B, Raoult D (2004): Acinetobacter baumannii in human body louse. Emerg Infect Dis 10: 1671-1673.
65. Lambert T, Gerbaud G, Courvalin P (1994): Characterization of the chromosomal aac(6')-Ij gene of Acinetobacter sp. 13 and the aac(6')-Ih plasmid gene of Acinetobacter baumannii. Antimicrob Agents Chemother 38: 1883-1889.
66. Landman D, Quale JM, Mayorga D, Adedeji A, Vangala K, Ravishankar J, Flores C, Brooks S (2002): Citywide clonal outbreak of multiresistant Acinetobacter baumannii and Pseudomonas aeruginosa in Brooklyn, NY: the preantibiotic era has returned. Arch Intern Med 162: 1515-1520.
67. Lemos EV, de la Hoz FP, Einarson TR, McGhan WF, Quevedo E, Castaneda C, Kawai K (2013): Carbapenem resistance and mortality in patients with Acinetobacter baumannii infection: systematic review and meta-analysis. Clin Microbiol Infect 20(5): 416-423.
68. Mahgoub S, Ahmed J, Glatt AE (2002): Completely resistant Acinetobacter baumannii strains. Infect Control Hosp Epidemiol 23: 477-479.
69. Maragakis LL, Perl TM (2008): Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. Clin Infect Dis 46: 1254-1263.
70. Mathewson JJ, Simpson RB (1982): Glucose-nonfermenting Gram-negative bacilli associated with clinical veterinary specimens. J Clin Microbiol 15: 1016-1018.
71. McDonald LC, Banerjee SN, Jarvis WR (1999): Seasonal variation of Acinetobacter infections: 1987-1996. Nosocomial Infections Surveillance System. Clin Infect Dis 29: 1133-1137.
72. Mohri T, Takashima K, Yamane T, Sato H, Yamane Y (2009): Purulent pericarditis in a dog administered immune-suppressing drugs. J Vet Med Sci 71: 669-672.
73. Moore CP, Collins BK, Fales WH (1995): Antibacterial susceptibility patterns for microbial isolates associated with infectious keratitis in horses: 63 cases (1986-1994). J Am Vet Med Assoc 207: 928-933.
74. Mugnier PD, Poirel L, Naas T, Nordmann P (2010): Worldwide dissemination of the blaOXA-23 carbapenemase gene of Acinetobacter baumannii. Emerg Infect Dis 16: 35-40.
75. Muller MG, George AR, Walochnik J (2010): Acinetobacter baumannii in Localised Cutaneous Mycobacteriosis in Falcons. Vet Med Int 2010.
76. Murphy CP, Reid-Smith RJ, Boerlin P, Weese JS, Prescott JF, Janecko N, McEwen SA (2012): Out-patient antimicrobial drug use in dogs and cats for new disease events from community companion animal practices in Ontario. Can Vet J 53: 291-298.
77. Naas T, Coignard B, Carbonne A, Blanckaert K, Bajolet O, Bernet C, Verdeil X, Astagneau P, Desenclos JC, Nordmann P; French Nosocomial Infection Early Warning Investigation and Surveillance Network (2006): VEB-1 Extended-spectrum beta-lactamase-producing Acinetobacter baumannii, France. Emerg Infect Dis 12: 1214-1222.
78. Naas T, Kernbaum S, Allali S, Nordmann P (2007): Multidrugresistant Acinetobacter baumannii, Russia. Emerg Infect Dis 13: 669-671.
79. Nam HM, Lim SK, Kang HM, Kim JM, Moon JS, Jang KC, Kim JM, Joo YS, Jung SC (2009): Prevalence and antimicrobial susceptibility of gram-negative bacteria isolated from bovine mastitis between 2003 and 2008 in Korea. J Dairy Sci 92: 2020-2026.
80. Nam HM, Lim SK, Kim JM, Joo YS, Jang KC, Jung SC (2010): In vitro activities of antimicrobials against six important species of gram-negative bacteria isolated from raw milk samples in Korea. Foodborne Pathog Dis 7: 221-224.
81. Nemec A, Dijkshoorn L, van der Reijden TJ (2004a): Long-term predominance of two pan-European clones among multi-resistant Acinetobacter baumannii strains in the Czech Republic. J Med Microbiol 53: 147-153.
82. Nemec A, Dolzani L, Brisse S, van den Broek P, Dijkshoorn L (2004b): Diversity of aminoglycoside-resistance genes and their association with class 1 integrons among strains of pan- European Acinetobacter baumannii clones. J Med Microbiol 53: 1233-1240.
83. O'Shea MK (2012): Acinetobacter in modern warfare. Int J Antimicrob Agents 39: 363-375.
84. Peleg AY, Bell JM, Hofmeyr A, Wiese P (2006): Inter-country transfer of Gram-negative organisms carrying the VIM-4 and OXA-58 carbapenem-hydrolysing enzymes. J Antimicrob Chemother 57: 794-795.
85. Peleg AY, Seifert H, Paterson DL (2008): Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 21: 538-582.
86. Perez F, Hujer AM, Hujer KM, Decker BK, Rather PN, Bonomo RA (2007): Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother 51: 3471-3484.
87. Phillips I, Casewell M, Cox T, De Groot B, Friis C, Jones R, Nightingale C, Preston R, Waddell J (2004): Does the use of antibiotics in food animals pose a risk to human health? A critical review of published data. J Antimicrob Chemother 53: 28-52.
88. Poirel L, Nordmann P (2006a): Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin Microbiol Infect 12: 826-836.
89. Poirel L, Nordmann P (2006b): Genetic structures at the origin of acquisition and expression of the carbapenem-hydrolyzing oxacillinase gene blaOXA-58 in Acinetobacter baumannii. Antimicrob Agents Chemother 50: 1442-1448.
90. Poirel L, Bonnin RA, Nordmann P (2011): Genetic basis of antibiotic resistance in pathogenic Acinetobacter species. IUBMB Life 63: 1061-1067.
91. Poirel L, Bercot B, Millemann Y, Bonnin RA, Pannaux G, Nordmann P (2012): Carbapenemase-producing Acinetobacter spp. in Cattle, France. Emerg Infect Dis 18: 523-525.
92. Pomba C, Endimiani A, Rossano A, Saial D, Couto N, Perreten V (2014): First Report of OXA-23-mediated carbapenem resistance in sequence type 2 multidrug-resistant Acinetobacter baumannii associated with urinary tract infection in a cat. Antimicrob Agents Chemother 58: 1267-1268.
93. Rahman H, Baxi KK (1985): Isolation of Acinetobacter calcoaceticus from a cow with mastitis. Zentralbl Veterinarmed B 32: 71-72.
94. Rajasekhar M, Muniyappa L, Murthy BS (1978): Chronic haematuria caused by Acinetobacter calcoaceticus in a race horse. Vet Rec 102: 557.
95. Ribera A, Ruiz J, Vila J (2003): Presence of the Tet M determinant in a clinical isolate of Acinetobacter baumannii. Antimicrob Agents Chemother 47: 2310-2312.
96. Roca I, Marti S, Espinal P, Martinez P, Gibert I, Vila J (2009): CraA, a major facilitator superfamily efflux pump associated with chloramphenicol resistance in Acinetobacter baumannii. Antimicrob Agents Chemother 53: 4013-4014.
97. Saphir DA, Carter GR (1976): Gingival flora of the dog with special reference to bacteria associated with bites. J Clin Microbiol 3: 344-349.
98. Schulte B, Goerke C, Weyrich P, Grobner S, Bahrs C, Wolz C, Autenrieth IB, Borgmann S (2005): Clonal spread of meropenem- resistant Acinetobacter baumannii strains in hospitals in the Mediterranean region and transmission to South-west Germany. J Hosp Infect 61: 356-357.
99. Schwarz S, Silley P, Simjee S, Woodford N, van Duijkeren E, Johnson AP, Gaastra W (2010): Editorial: assessing the antimicrobial susceptibility of bacteria obtained from animals. J Antimicrob Chemother 65: 601-604.
100. Sechi LA, Karadenizli A, Deriu A, Zanetti S, Kolayli F, Balikci E, Vahaboglu H (2004): PER-1 type beta-lactamase production in Acinetobacter baumannii is related to cell adhesion. Med Sci Monit 10: BR180-184.
101. Segal H, Garny S, Elisha BG (2005): Is IS(ABA-1) customized for Acinetobacter? FEMS Microbiol Lett 243: 425-429.
102. Seifert H, Strate A, Pulverer G (1995): Nosocomial bacteremia due to Acinetobacter baumannii. Clinical features, epidemiology, and predictors of mortality. Medicine (Baltimore) 74: 340-349.
103. Seward RJ, Lambert T, Towner KJ (1998): Molecular epidemiology of aminoglycoside resistance in Acinetobacter spp. J Med Microbiol 47: 455-462.
104. Tuon FF, Penteado-Filho SR, Amarante D, Andrade MA, Borba LA (2010): Mortality rate in patients with nosocomial Acinetobacter meningitis from a Brazilian hospital. Braz J Infect Dis 14: 437-440.
105. Turton JF, Kaufmann ME, Warner M, Coelho J, Dijkshoorn L, van der Reijden T, Pitt TL (2004): A prevalent, multiresistant clone of Acinetobacter baumannii in Southeast England. J Hosp Infect 58: 170-179.
106. Turton JF, Ward ME, Woodford N, Kaufmann ME, Pike R, Livermore DM, Pitt TL (2006): The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. FEMS Microbiol Lett 258: 72-77.
107. Van Dessel H, Dijkshoorn L, van der Reijden T, Bakker N, Paauw A, van den Broek P, Verhoef J, Brisse S (2004): Identification of a new geographically widespread multiresistant Acinetobacter baumannii clone from European hospitals. Res Microbiol 155: 105-112.
108. Vaneechoutte M, Devriese LA, Dijkshoorn L, Lamote B, Deprez P, Verschraegen G, Haesebrouck F (2000): Acinetobacter baumannii- infected vascular catheters collected from horses in an equine clinic. J Clin Microbiol 38: 4280-4281.
109. Vila J, Pachon J (2008): Therapeutic options for Acinetobacter baumannii infections. Expert Opin Pharmacother 9: 587-599.
110. Vila J, Marcos A, Marco F, Abdalla S, Vergara Y, Reig R, Gomez- Lus R, Jimenez de Anta T (1993): In vitro antimicrobial production of beta-lactamases, aminoglycoside-modifying enzymes, and chloramphenicol acetyltransferase by and susceptibility of clinical isolates of Acinetobacter baumannii. Antimicrob Agents Chemother 37: 138-141.
111. Vila J, Ruiz J, Goni P, Marcos A, Jimenez de Anta T (1995): Mutation in the gyrA gene of quinolone-resistant clinical isolates of Acinetobacter baumannii. Antimicrob Agents Chemother 39: 1201-1203.
112. Vila J, Ruiz J, Goni P, Jimenez de Anta T (1997): Quinoloneresistance mutations in the topoisomerase IV parC gene of Acinetobacter baumannii. J Antimicrob Chemother 39: 757-762.
113. Vila J, Ruiz J, Navia M, Becerril B, Garcia I, Perea S, Lopez-Hernandez I, Alamo I, Ballester F, Planes AM, Martinez-Beltran J, de Anta TJ (1999): Spread of amikacin resistance in Acinetobacter baumannii strains isolated in Spain due to an epidemic strain. J Clin Microbiol 37: 758-761.
114. Vila J, Marti S, Sanchez-Cespedes J (2007): Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii. J Antimicrob Chemother 59: 1210-1215.
115. Visca P, Seifert H, Towner KJ (2011): Acinetobacter infection - an emerging threat to human health. IUBMB Life 63: 1048-1054.
116. Wadl M, Heckenbach K, Noll I, Ziesing S, Pfister W, Beer J, Schubert S, Eckmanns T (2010): Increasing occurrence of multidrug- resistance in Acinetobacter baumannii isolates from four German University Hospitals, 2002-2006. Infection 38: 47-51.
117. Wisplinghoff H, Seifert H (2012): Clinical features and therapeutic options of Acinetobacter baumannii infections. Hyg Med 37(1/2): 8-15.
118. Wisplinghoff H, Seifert, H (2014): Infektionen mit Acinetobacter baumannii beim Menschen - Epidemiologie und klinische Bedeutung. Berl Muench Tieraerztl Wochenschr 127: 447-457.
119. Yang YS, Lee YT, Huang TW, Sun JR, Kuo SC, Yang CH, Chen TL, Lin JC, Fung CP, Chang FY (2013): Acinetobacter baumannii nosocomial pneumonia: is the outcome more favorable in nonventilated than ventilated patients? BMC Infect Dis 13: 142.
120. Zarrilli R, Pournaras S, Giannouli M, Tsakris A (2013): Global evolution of multidrug-resistant Acinetobacter baumannii clonal lineages. Int J Antimicrob Agents 41: 11-19.
121. Zeana C, Larson E, Sahni J, Bayuga SJ, Wu F, Della-Latta P (2003): The epidemiology of multidrug-resistant Acinetobacter baumannii: does the community represent a reservoir? Infect Control Hosp Epidemiol 24: 275-279.
122. Zhang WJ, Lu Z, Schwarz S, Zhang RM, Wang XM, Si W, Yu S, Chen L, Liu S (2013): Complete sequence of the bla(NDM- 1)-carrying plasmid pNDM-AB from Acinetobacter baumannii of food animal origin. J Antimicrob Chemother 68: 1681-1682.
123. Zordan S (2011): Diversität und Klonalität multiresistenter Acinetobacter- Stämme von Patienten deutscher Tierkliniken und Tierarztpraxen. Gießen, Justus-Liebig-Universität, Diss.
124. Zorda n S, Prenger-Berninghoff E, Weiss R, van der Reijden T, van den Broek P, Baljer G, Dijkshoorn L (2011): Multidrugresistant Acinetobacter baumannii in veterinary clinics, Germany. Emerg Infect Dis 17: 1751-1754.